Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
Structure-activity studies of endothelin leading to novel peptide ETA antagonists. [electronic resource] by
- Hunt, J T
- Lee, V G
- McMullen, D
- Liu, E C
- Bolgar, M
- Delaney, C L
- Festin, S M
- Floyd, D M
- Hedberg, A
- Natarajan, S
Producer: 19941011
In:
Bioorganic & medicinal chemistry vol. 1
Availability: No items available.
|
|
16.
|
The discovery of sulfonamide endothelin antagonists and the development of the orally active ETA antagonist 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulf onamide. [electronic resource] by
- Stein, P D
- Hunt, J T
- Floyd, D M
- Moreland, S
- Dickinson, K E
- Mitchell, C
- Liu, E C
- Webb, M L
- Murugesan, N
- Dickey, J
Producer: 19940315
In:
Journal of medicinal chemistry vol. 37
Availability: No items available.
|
|
17.
|
Benzazepinone calcium channel blockers. 5. Effects on antihypertensive activity associated with N1 and aromatic substituents. [electronic resource] by
- Das, J
- Floyd, D M
- Kimball, S D
- Duff, K J
- Lago, M W
- Krapcho, J
- White, R E
- Ridgewell, R E
- Obermeier, M T
- Moreland, S
Producer: 19920826
In:
Journal of medicinal chemistry vol. 35
Availability: No items available.
|
|
18.
|
Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site. [electronic resource] by
- Kimball, S D
- Floyd, D M
- Das, J
- Hunt, J T
- Krapcho, J
- Rovnyak, G
- Duff, K J
- Lee, V G
- Moquin, R V
- Turk, C F
Producer: 19920403
In:
Journal of medicinal chemistry vol. 35
Availability: No items available.
|
|
19.
|
Discovery and structure-activity relationships of sulfonamide ETA-selective antagonists. [electronic resource] by
- Stein, P D
- Floyd, D M
- Bisaha, S
- Dickey, J
- Girotra, R N
- Gougoutas, J Z
- Kozlowski, M
- Lee, V G
- Liu, E C
- Malley, M F
Producer: 19950531
In:
Journal of medicinal chemistry vol. 38
Availability: No items available.
|
|
20.
|
Dihydropyrimidine calcium channel blockers. 2. 3-substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines. [electronic resource] by
- Atwal, K S
- Rovnyak, G C
- Kimball, S D
- Floyd, D M
- Moreland, S
- Swanson, B N
- Gougoutas, J Z
- Schwartz, J
- Smillie, K M
- Malley, M F
Producer: 19901004
In:
Journal of medicinal chemistry vol. 33
Availability: No items available.
|